SecSonar.com

Rockwell Medical, Inc. (RMTI)

Rockwell Medical, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Rockwell Medical, Inc. (RMTI) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $29.3M. Revenue declined 31.8% year-over-year and free cash flow was negative at -$1.2M. This page tracks RMTI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 244 employees · IPO Jan 27, 1998

Valuation

Valuation & price

$0.79 · as of May 17, 2026 · -95.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.79

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$18.00$11.77$5.54Jul 25Dec 25Jul 26Jul 7, 25$7.97Jul 9, 25$11.90Jul 11, 25$11.30Jul 15, 25$10.90Jul 17, 25$10.90Jul 21, 25$11.20Jul 23, 25$11.20Jul 25, 25$10.70Jul 29, 25$10.20Jul 31, 25$9.30Aug 4, 25$9.92Aug 6, 25$9.66Aug 11, 25$9.44Aug 13, 25$10.50Aug 15, 25$10.20Aug 19, 25$10.50Aug 21, 25$11.60Aug 25, 25$13.00Aug 27, 25$14.70Aug 29, 25$17.10Sep 3, 25$17.30Sep 5, 25$16.20Sep 9, 25$18.00Sep 11, 25$16.90Sep 16, 25$16.80Sep 18, 25$13.30Sep 22, 25$13.10Sep 24, 25$12.60Sep 26, 25$12.70Sep 30, 25$12.00Oct 2, 25$12.10Oct 6, 25$12.10Oct 8, 25$12.10Oct 10, 25$11.00Oct 14, 25$12.00Oct 16, 25$11.90Oct 21, 25$11.80Oct 23, 25$11.50Oct 27, 25$11.40Oct 29, 25$10.90Oct 31, 25$11.10Nov 4, 25$10.40Nov 6, 25$10.10Nov 10, 25$10.70Nov 12, 25$9.55Nov 14, 25$9.19Nov 18, 25$8.75Nov 20, 25$8.56Nov 25, 25$9.15Nov 28, 25$9.95Dec 2, 25$9.49Dec 4, 25$10.20Dec 8, 25$9.10Dec 10, 25$9.60Dec 12, 25$9.25Dec 16, 25$8.30Dec 18, 25$8.50Dec 22, 25$8.43Dec 24, 25$8.09Dec 29, 25$8.09Jan 2, 26$8.63Jan 6, 26$9.26Jan 8, 26$9.78Jan 12, 26$9.96Jan 14, 26$9.57Jan 16, 26$9.57Jan 21, 26$12.30Jan 23, 26$11.50Jan 27, 26$11.50Jan 29, 26$10.90Feb 2, 26$11.40Feb 4, 26$10.30Feb 9, 26$10.80Feb 11, 26$10.90Feb 13, 26$10.10Feb 18, 26$10.50Feb 20, 26$9.53Feb 24, 26$9.40Feb 26, 26$9.31Mar 2, 26$9.00Mar 4, 26$8.92Mar 6, 26$8.66Mar 10, 26$8.85Mar 12, 26$8.97Mar 17, 26$10.60Mar 19, 26$10.30Mar 23, 26$10.20Mar 25, 26$10.40Mar 27, 26$8.70Mar 31, 26$8.93Apr 2, 26$9.57Apr 7, 26$9.50Apr 9, 26$9.30Apr 13, 26$9.40Apr 15, 26$9.17Apr 17, 26$9.14Apr 22, 26$8.60Apr 24, 26$8.73Apr 28, 26$8.90Apr 30, 26$8.77May 4, 26$8.90May 6, 26$8.10May 8, 26$8.34May 12, 26$8.43May 14, 26$7.97May 18, 26$7.81May 20, 26$8.20May 22, 26$7.93May 28, 26$7.57Jun 1, 26$7.18Jun 3, 26$6.76Jun 5, 26$6.65Jun 9, 26$6.86Jun 11, 26$6.23Jun 15, 26$6.42Jun 17, 26$6.51Jun 22, 26$6.69Jun 24, 26$6.79Jun 26, 26$6.51Jul 2, 26$5.54
$5.1952-week range$18.30
Loading valuation history…

Fundamentals

Key fundamentals

$29.3M

Market cap

-31.8%

Revenue growth (YoY)

16.9%

Gross margin

-$1.2M

Free cash flow (USD)

-$12.5M

Net debt

Net cash position

15.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$53.3MFY 2017$57.3MFY 2018$63.4MFY 2019$61.3MFY 2020$62.2MFY 2021$61.9MFY 2022$72.8MFY 2023$83.6MFY 2024$101.5MFY 2025$69.3M
$53.3M$69.3M

Free cash flow by year

2016 → 2025

FY 2016$-12.8MFY 2017$-22.8MFY 2018$-21.4MFY 2019$-28.6MFY 2020$-30.7MFY 2021$-34.1MFY 2022$-17.2MFY 2023$-9.7MFY 2024$3.2MFY 2025$-1.2M
-$12.8M-$1.2M

Gross margin by year

2021 → 2025

FY 2021-3.9%FY 20225.6%FY 202310.4%FY 202417.2%FY 202516.9%
-3.9%16.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventReverse Stock SplitJun 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • 8-K eventDelisting NoticeMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCorporate Presentation UpdateMay 7, 2026Filing

Questions

Frequently asked questions

What is Rockwell Medical, Inc.'s market cap?

Rockwell Medical, Inc. (RMTI) has a market capitalization of $29.3M.

What is RMTI's P/E ratio?

A meaningful P/E ratio is not available for RMTI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RMTI's price-to-book (P/B) ratio?

RMTI trades at 0.79 times book value per share.

Are insiders buying RMTI stock?

SEC Form 4 filings show no open-market insider buys at Rockwell Medical, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

TXMD

TherapeuticsMD, Inc.

$24.2M

SCYX

SCYNEXIS, Inc.

$37.7M

OPTH

Optimi Health Corp.

$19.6M

ZYBT

Zhengye Biotechnology Holding Limited

$39.4M

IXHL

Incannex Healthcare Limited

$39.6M

AYTU

Aytu BioPharma, Inc.

$17.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.